Alexion (AstraZeneca) Deal History & Licensing Activity

About Alexion (AstraZeneca) Licensing & Deal Activity

Alexion (AstraZeneca) is a large pharma company based in UK that has been actively engaged in licensing transactions across the biopharma landscape. With 20 deals over the past three years, Alexion (AstraZeneca) ranks among the most acquisitive companies tracked by Ambrosia Ventures.

Key therapeutic areas of focus for Alexion (AstraZeneca) include Solid Tumors (14 deals and trials), Mega Deals (11 deals and trials), Option Deals (10 deals and trials), and Cardiovascular (7 deals and trials). In terms of modality, Alexion (AstraZeneca) has shown particular interest in other, small molecules, small molecules.

Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Alexion (AstraZeneca) and 850+ other biopharma companies. Use our Solidus to benchmark your asset against Alexion (AstraZeneca)'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.